Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the third quarter ended September 30, 2025, and refined full year 2025 financial guidance.

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Gemini ative Model Support for Livekit Agents with Vertex AI not working #3714 Open sanskritipattanayak opened 2 days ago ...

Abstract: Multipath Routing plays an important role in communication networks. Multiple disjoint paths can increase the effective bandwidth between pairs of vertices, avoid congestion in a network and ...